The effect of graft allocation system on outcomes in heart transplantation in France: Has the time come to take calculated survival benefit into account?

Journal of Heart and Lung Transplantation

Volumn 30, Issue 11, 2011, Pages 1299-1300

  Dorent, Richard ^a   Epailly, Eric ^b   Sebbag, Laurent ^c  

^a Directrice Générale de l'Agence de la Biomédecine   (France)

^b HÔPITAL CIVIL   (France)

^c LOUIS PRADEL HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INOTROPIC AGENT;

ARTIFICIAL VENTILATION; EMERGENCY HEALTH SERVICE; FOLLOW UP; FRANCE; GRAFT ALLOCATION SYSTEM; GRAFT SURVIVAL; HEALTH CARE SYSTEM; HEART ASSIST DEVICE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; IMPLANT REGISTRY; NOTE; ORGAN DONOR; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL TIME; THROMBOEMBOLISM;

EID: 80053933339     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2011.06.008     Document Type: Letter

References (3)

1. M.C. Deng, J.M. De Meester, J.M. Smits, J. Heinecke, and H.H. Scheld Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group BMJ 321 2000 540 545
2. H. Krakauer, M.J. Lin, and R.C. Bailey Projected survival benefit as criterion for listing and organ allocation in heart transplantation J Heart Lung Transplant 24 2005 680 689 (Pubitemid 40798250)
3. J.H. Ware The limitations of risk factors as prognostic tools N Engl J Med 355 2006 2615 2617 (Pubitemid 44969120)